SLC39A7 and osteoporosis: Further investigation of the SLC39A7 expression levels in MSCs revealed that, compared with the control group, the osteoporosis group had significantly elevated SLC39A7 mRNA and protein levels (Fig. 3G and H), which was consistent with the findings in bone tissue sections.